Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cinnamaldehyde + BAM8-22
- Development stage
- Unknown
- Lead developer
- Aalborg University
- Modality
- Peptides, Small Molecules
- Administration
- Topical, Intradermal
01
Overview
CA + BAM8-22 is an experimental research combination consisting of cinnamaldehyde (CA) and the peptide Bovine Adrenal Medulla 8-22 (BAM8-22). This combination is utilized as a surrogate model to study non-histaminergic itch pathways, specifically investigating the interaction between the Mas-related G protein-coupled receptor X1 (MrgprX1) and the Transient Receptor Potential Ankyrin 1 (TRPA1) ion channel. BAM8-22 acts as a potent agonist of MrgprX1, which induces itch through the Gαq/11 pathway and downstream TRPA1 activation. Cinnamaldehyde is a known exogenous agonist of TRPA1. The combination is primarily used in clinical research settings, such as those conducted by Aalborg University, to characterize the mechanisms of chronic itch in healthy human volunteers.
- Other names
- trans-cinnamaldehyde + Bovine Adrenal Medulla 8-22
02
Targets
MrgprC11 (Mas-related G protein-coupled receptor C11)TRPA1 (Transient receptor potential cation channel subfamily A member 1)MRGPRX1 (Mas-related G protein-coupled receptor X1)
Beyond the preview
Go deeper on cinnamaldehyde + BAM8-22.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cinnamaldehyde + BAM8-22.